VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 94 filers reported holding VISTAGEN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $39,393 | +21.1% | 315,900 | 0.0% | 0.00% | – |
| Q4 2022 | $32,538 | +20.5% | 315,900 | +76.8% | 0.00% | – |
| Q3 2022 | $27,000 | -6.9% | 178,700 | +439.9% | 0.00% | – |
| Q2 2022 | $29,000 | +7.4% | 33,100 | +53.2% | 0.00% | – |
| Q1 2022 | $27,000 | -64.9% | 21,600 | -45.5% | 0.00% | – |
| Q4 2021 | $77,000 | -29.4% | 39,600 | 0.0% | 0.00% | – |
| Q3 2021 | $109,000 | -12.8% | 39,600 | 0.0% | 0.00% | – |
| Q2 2021 | $125,000 | – | 39,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|